ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models.

Caitlin D Lowery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.